Stocks
Allogene Therapeutics (ALLO) Net margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -636.1% | -135 726% | -344 489% | -659 137% | ||||
| Changes by years, y/y, % | -135 090pp | -208 763pp | +2 227.1% | ||||||
Allogene Therapeutics. Net margin, %
Allogene Therapeutics. Net margin, changes, pp
Allogene Therapeutics (ALLO) Net margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net margin, % | ? | -189 112% | -177 248% | -142 593% | -408 467% | -295 455% | -659 137% | |
| Changes by years, y/y, % | -58 443pp | -90 652pp | +25 052pp | -209 913pp | -106 343pp | |||
| Changes by quarters, q/q, % | +9 442pp | +11 864pp | +34 655pp | -265 874pp | +113 012pp | |||
